More frequent side effects include: fever.
See below for a comprehensive list of adverse effects.
Frequency not reported: Angina, arrhythmia, palpitations, increased or decreased pulse, tachycardia, increased or decreased blood pressure, cerebral arteritis and/or occlusionPostmarketing reports: Peripheral vasculopathy (including Raynaud's phenomenon)
Very common (10% or more): Psychiatric disorders (up to 46%), insomnia (up to 17%), feeling jittery (up to 12%), anxiety (up to 11%)Common (1% to 10%): Depression, mood swings, irritabilityFrequency not reported: Transient depressed mood, aggressive behavior, libido changes (all reported by patients taking methylphenidate)
Very common (10% or more): Nervous system disorders (up to 50%), headache (up to 39%)Common (1% to 10%): DizzinessFrequency not reported: Drowsiness, dyskinesia, headache, Tourette's syndrome, toxic psychosis, neuroleptic malignant syndrome (reported by patients taking methylphenidate)
Frequency not reported: Hypersensitivity reactions (including angioedema, anaphylaxis, skin rash, urticaria, fever, arthralgia, exfoliative dermatitis, erythema multiforme with histopathological findings of necrotizing vasculitis, and thrombocytopenic purpura)
Postmarketing reports: Rhabdomyolysis
Very common (10% or more): GI disorders (up to 44%), dry mouth (up to 20%), abdominal pain (up to 15%)Common (1% to 10%): Dyspepsia, nausea, vomiting
Very common (10% or more): Metabolism/nutrition disorders (up to 34%), decreased appetite (up to 30%)Common (1% to 10%): AnorexiaFrequency not reported: Weight loss during prolonged therapy
Very common (10% or more): Respiratory/thoracic/mediastinal disorders (up to 16%)Common (1% to 10%): Nasal congestion, pharyngolaryngeal pain
Common (1% to 10%): PruritusFrequency not reported: Scalp hair loss (reported by patients taking methylphenidate)
Common (1% to 10%): Fever
Frequency not reported: Priapism (reported by patients taking methylphenidate)
Frequency not reported: Leukopenia and/or anemia (reported by patients taking methylphenidate)
Frequency not reported: Abnormal liver function (ranging from transaminase elevation to hepatic coma; reported by patients taking methylphenidate)
Nervousness and insomnia are the most common adverse reactions reported with other methylphenidate products.
In children, the following adverse reactions may occur more frequently: loss of appetite, abdominal pain, weight loss during prolonged therapy, insomnia, and tachycardia.
Fast, pounding, or irregular heartbeat
Blurred vision
vision changes
Convulsions
jerking of the arms and legs
muscle spasm
sudden loss of consciousness
Acid or sour stomach
belching
heartburn
indigestion
loss of appetite
nausea
stomach discomfort, upset, or pain
throat pain
weight loss
Twitching